DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,768,065 | +1.7% | 87,739 | -1.7% | 1.47% | +5.9% |
| Q2 2023 | $21,410,659 | -5.5% | 89,211 | -0.8% | 1.39% | -8.3% |
| Q1 2023 | $22,656,904 | -5.6% | 89,894 | -0.6% | 1.51% | -9.7% |
| Q4 2022 | $23,997,969 | +4.5% | 90,415 | +1.7% | 1.68% | -0.3% |
| Q3 2022 | $22,973,000 | +0.2% | 88,942 | -1.7% | 1.68% | +6.3% |
| Q2 2022 | $22,937,000 | -12.2% | 90,473 | +1.6% | 1.58% | +4.4% |
| Q1 2022 | $26,126,000 | +106.3% | 89,066 | -40.1% | 1.52% | +457.0% |
| Q3 2015 | $12,663,000 | -0.7% | 148,600 | -0.3% | 0.27% | -1.1% |
| Q2 2015 | $12,750,000 | +7.1% | 148,975 | +6.3% | 0.28% | +10.4% |
| Q1 2015 | $11,901,000 | -1.4% | 140,172 | -0.4% | 0.25% | -5.7% |
| Q4 2014 | $12,067,000 | +14.0% | 140,792 | +1.0% | 0.26% | +10.9% |
| Q3 2014 | $10,588,000 | -0.8% | 139,355 | +2.8% | 0.24% | +3.0% |
| Q2 2014 | $10,675,000 | +1.3% | 135,595 | -3.5% | 0.23% | -1.3% |
| Q1 2014 | $10,543,000 | -2.0% | 140,569 | +0.9% | 0.23% | +2.6% |
| Q4 2013 | $10,754,000 | +24.4% | 139,310 | +11.7% | 0.23% | +9.1% |
| Q3 2013 | $8,646,000 | +1.0% | 124,727 | -7.7% | 0.21% | -6.7% |
| Q2 2013 | $8,557,000 | – | 135,179 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |